PDS Biotechnology Corp Lessee, Operating Lease, Liability, Undiscounted Excess Amount
PDS Biotechnology Corp (PDSB) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $683 as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2023-08-14
- 2023-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $683.00.
- 2023-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.39K.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8.04K.
- 2022-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $14.60K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2023-06-30 | $683.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.39K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $8.04K 10-K · filed 2023-03-28 |
| 2022-09-30 | $14.60K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $23.01K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $33.13K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $44.10K 10-K · filed 2022-03-31 |
| 2021-09-30 | $55.80K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $67.55K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $81.65K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $95.39K 10-K · filed 2021-03-18 |
| 2019-06-30 | $164.61K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $198.68K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |